Resources Contact Us Home
Methods for identifying, diagnosing, and predicting survival of lymphomas

Image Number 11 for United States Patent #8131475.

Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

  Recently Added Patents
Method and apparatus for a battery docking connector having reserve power for hot battery swap
Pet grooming brush and vacuum attachment
System and method for detecting crop rows in an agricultural field
Device and method for producing a fluidic connection between cavities
LED illumination systems
LCD driving circuit in which shift register units are driven by a first clock signal of fixed duty/amplitude and a second clock signal of variable duty/amplitude
Mounting structure, electro-optical apparatus, and touch panel
  Randomly Featured Patents
Beverage container
Spark plug connector
System for securing a key in a vehicle
Computer-to-cylinder type lithographic printing method and computer-to-cylinder type lithographic printing apparatus
Catalysts for the manufacture of polyurethanes and/or polyureas
Wellbore centralizer for tubulars
Electronic device and leadframe and methods for producing the electronic device and the leadframe
Tire tread grinding
Measurement of relative velocities
Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug